Company registration number 07350131 (England and Wales)
MALAKS MEDICAL LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
MALAKS MEDICAL LIMITED
CONTENTS
Page
Directors' report
1
Balance sheet
2
Notes to the financial statements
3 - 4
MALAKS MEDICAL LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 1 -
The directors present their annual report and financial statements for the year ended 30 November 2025.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Dr M T Malak
Dr T T Malak
Small companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
On behalf of the board
Dr M T Malak
Dr T T Malak
Director
Director
1 June 2026
MALAKS MEDICAL LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
167,039
165,184
Current assets
Cash at bank and in hand
168,319
162,922
Creditors: amounts falling due within one year
4
(4,047)
(2,866)
Net current assets
164,272
160,056
Net assets
331,311
325,240
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
331,211
325,140
Total equity
331,311
325,240
For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 1 June 2026 and are signed on its behalf by:
Dr M T Malak
Dr T T Malak
Director
Director
Company registration number 07350131 (England and Wales)
MALAKS MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information
Malaks Medical Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
1.3
Tangible fixed assets
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
not provided
Plant and equipment
25% on reducing balance
Computers
33.33% on cost
1.4
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
The directors chose not to provide deferred tax because they do not believe it is relevant, and accept that this contravenes the Accounting Standards in FRS 102 (Section 1A)
MALAKS MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 4 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
0
0
3
Tangible fixed assets
Freehold land and buildings
Plant and equipment
Computers
Total
£
£
£
£
Cost
At 1 December 2024
162,298
7,175
19,790
189,263
Additions
2,676
2,676
At 30 November 2025
162,298
7,175
22,466
191,939
Depreciation and impairment
At 1 December 2024
4,289
19,790
24,079
Depreciation charged in the year
721
100
821
At 30 November 2025
5,010
19,890
24,900
Carrying amount
At 30 November 2025
162,298
2,165
2,576
167,039
At 30 November 2024
162,298
2,886
165,184
4
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
1,332
201
Deferred income
1,350
1,300
Other creditors
1,365
1,365
4,047
2,866
5
Parent company
The company is controlled by the directors and majority shareholders.